These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17153381)

  • 1. Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs.
    Alterovitz R; Lessard E; Pouliot J; Hsu IC; O'Brien JF; Goldberg K
    Med Phys; 2006 Nov; 33(11):4012-9. PubMed ID: 17153381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
    Hsu IC; Lessard E; Weinberg V; Pouliot J
    Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
    Morton GC; Sankreacha R; Halina P; Loblaw A
    Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of using linear optimization models in dose planning for HDR brachytherapy.
    Holm A; Larsson T; Carlsson Tedgren A
    Med Phys; 2012 Feb; 39(2):1021-8. PubMed ID: 22320812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed integer programming improves comprehensibility and plan quality in inverse optimization of prostate HDR brachytherapy.
    Gorissen BL; den Hertog D; Hoffmann AL
    Phys Med Biol; 2013 Feb; 58(4):1041-57. PubMed ID: 23363622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
    Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
    Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns.
    Cunha JA; Hsu IC; Pouliot J
    Med Phys; 2009 Jan; 36(1):233-9. PubMed ID: 19235391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy.
    Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL
    Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prostate catheter displacement in inverse planning--simulated annealing and geometric optimization.
    Reynés-Llompart G; Pino F; Modolell I; Gullón C; Pera J; Gutierrez C; Picón C
    Brachytherapy; 2016; 15(1):112-7. PubMed ID: 26612698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist.
    Lessard E; Kwa SL; Pickett B; Roach M; Pouliot J
    Med Phys; 2006 Aug; 33(8):2773-82. PubMed ID: 16964853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.
    Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy.
    Balvert M; Gorissen BL; den Hertog D; Hoffmann AL
    Phys Med Biol; 2015 Jan; 60(2):537-48. PubMed ID: 25549084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Wu X
    Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IPIP: A new approach to inverse planning for HDR brachytherapy by directly optimizing dosimetric indices.
    Siauw T; Cunha A; Atamtürk A; Hsu IC; Pouliot J; Goldberg K
    Med Phys; 2011 Jul; 38(7):4045-51. PubMed ID: 21859003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy.
    Panettieri V; Smith RL; Mason NJ; Millar JL
    J Appl Clin Med Phys; 2014 Nov; 15(6):5055. PubMed ID: 25493531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
    Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
    Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
    Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization for high-dose-rate brachytherapy of cervical cancer with adaptive simulated annealing and gradient descent.
    Yao R; Templeton AK; Liao Y; Turian JV; Kiel KD; Chu JC
    Brachytherapy; 2014; 13(4):352-60. PubMed ID: 24359671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.